Deep brain stimulation (DBS) is an established neurosurgical technique used to treat a variety of neurological disorders, including Parkinson disease, essential tremor, dystonia, epilepsy, depression, and obsessive-compulsive disorder. This study reports on the use of intraoperative MR imaging during DBS surgery to evaluate acute hemorrhage, intracranial air, brain shift, and accuracy of lead placement.
During a 46-month period, 143 patients underwent 152 DBS surgeries including 289 lead placements utilizing intraoperative 1.5-T MR imaging. Imaging was supervised by an MR imaging physicist to maintain the specific absorption rate below the required level of 0.1 W/kg and always included T1 magnetization-prepared rapid gradient echo and T2* gradient echo sequences with selected use of T2 fluid attenuated inversion recovery (FLAIR) and T2 fast spin echo (FSE). Retrospective review of the intraoperative MR imaging examinations was performed to quantify the amount of hemorrhage and the amount of air introduced during the DBS surgery.
Intraoperative MR imaging revealed 5 subdural hematomas, 3 subarachnoid hemorrhages, and 1 intraparenchymal hemorrhage in 9 of the 143 patients. Only 1 patient experiencing a subarachnoid hemorrhage developed clinically apparent symptoms, which included transient severe headache and mild confusion. Brain shift due to intracranial air was identified in 144 separate instances.
Intraoperative MR imaging can be safely performed and may assist in demonstrating acute changes involving intracranial hemorrhage and air during DBS surgery. These findings are rarely clinically significant and typically resolve prior to follow-up imaging. Selective use of T2 FLAIR and T2 FSE imaging can confirm the presence of hemorrhage or air and preclude the need for CT examinations.
Abbreviations used in this paper: DBS = deep brain stimulation; FLAIR = fluid attenuated inversion recovery; FSE = fast spin echo; GRE = gradient echo; MR-RAGE = magnetization-prepared rapid gradient echo; SAR = specific absorption rates; VIM = ventral intermediate nucleus.
ChhabraVSungEMewesKBakayRAAboschAGrossRE: Safety of magnetic resonance imaging of deep brain stimulator systems: a serial imaging and clinical retrospective study. Clinical article. J Neurosurg112:497–5022010
Deep-Brain Stimulation for Parkinson's Disease Study Group: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med345:956–9632001
FiebachJBSchellingerPDGassAKucinskiTSieblerMVillringerA: Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke35:502–5062004
HendersonJMTkachJPhillipsMBakerKShellockFGRezaiAR: Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report. Neurosurgery57:E10632005
Medtronic: MRI Guidelines for Medtronic Deep Brain Stimulation SystemsMinneapolisMedtronic Inc2007. (http://professional.medtronic.com/wcm/groups/mdtcom_sg/@mdt/@neuro/documents/documents/dbs-2007-mri.pdf) [Accessed May 24 2011]
SpiegelJFussGBackensMReithWMagnusTBeckerG: Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease. Case report. J Neurosurg99:772–7742003
StarrPAMartinAJOstremJLTalkePLevesqueNLarsonPS: Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. Clinical article. J Neurosurg112:479–4902010
US Federal Food and Drug Administration FDA Public Health Notification: MRI-caused injuries in patients with implated neurological stimulatorsMay102005. (http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062125.htm) [Accessed May 24 2011]